Winsford, Cheshire-based tissue healing technologies firm Advanced Medical Solutions Group plc (AMS) has confirmed media speculation that it is in discussions with London private equity firm TA Associates (UK), LLP regarding a possible offer for the entire issued and to be issued share capital of AMS.

AMS shares rose about 16% to around £2.64 to give the firm a stock market value of roughly £582 million.

“There can be no certainty that a firm offer will be made for AMS, nor as to the terms on which a firm offer might be made,” said AMS.

“A further announcement will be made as and when appropriate.

“In accordance with Rule 2.6(a) of the Code, TA is required, by no later than 5.00 p.m. (London time) on 16 May 2026, being 28 days after today’s date, to either announce a firm intention to make an offer for AMS in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies.

“This deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.

“As a consequence of this announcement, the Company is now in an “offer period” as defined in the Code and the attention of the Company’s shareholders is drawn to the dealing disclosure requirements of Rule 8 of the Code, which are summarised below.”